which glp-1 agonists have cardiovascular benefit Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action The Role of GLP-1RA Medications
Description
It's not uncommon, for example, to see some weight loss drugs negatively impact blood pressure and hypertension
Wong, H
PubMed, Pham, Hung, et al
Orforglipron significantly reduced HbA1c to 2.1% in a phase II clinical trial assessing its use in T2DM, while dulaglutide achieved 1.1% and a placebo achieved 0.43% [106]
19.Sanyal AJ, Newsome PN, Kliers I, stergaard LH, Long MT, Kjr MS, et al
Association of semaglutide with tobacco use disorder in patients with type 2 diabetes: target trial emulation using real-world data
